REBECCA SIGLER FNP-C NPI 1063066983

NPI Details

Rebecca Sigler, FNP-C is a family nurse practitioner in Pineville, LA with 6 years of experience. Rebecca Sigler, FNP-C NPI is 1063066983. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

2705 HIGHWAY 28 E
PINEVILLE, LA
ZIP 71360-712
Phone: (318) 704-6770

The NPI 1063066983 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Automated urinalysis test (HCPCS:81003)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• X-ray of chest, 2 views (HCPCS:71046)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Troponin (protein) analysis, quantitative (HCPCS:84484)
• Injection, cefazolin sodium, 500 mg (HCPCS:J0690)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• Injection of drug or substance into vein (HCPCS:96374)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)

The enumeration date for this NPI number is 7/29/2019 and was last updated on 7/29/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: